Who owns Teva Pharmaceutical Industries?

Key details on Teva Pharmaceutical Industries (Ticker: TEVA)

Who owns Teva Pharmaceutical Industries?

Is TEVA a good stock to own? Find out who bought Teva Pharmaceutical Industries, who sold Teva Pharmaceutical Industries (TEVA) stock, and who holds a large position in Teva Pharmaceutical Industries.

Fund Name Number of Shares Share Valuation As Of
Wellington Management Company 59.00M $2.23B Sept. 30, 2013
Capital Research Global Investors^ 48.43M $1.94B Dec. 31, 2013
Franklin Resources 43.09M $1.73B Dec. 31, 2013
Commerzbank Aktiengesellschaft 25.10M $995.84M March 31, 2013
MONDRIAN INVESTMENT PARTNERS 17.63M $931.58M March 31, 2014
Allianz Asset Management AG 16.12M $646.15M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 13.23M $530.39M Dec. 31, 2013
Barrow, Hanley, Mewhinney & Strauss 12.14M $486.71M Dec. 31, 2013
Soros Fund Management 10.74M $430.50M Dec. 31, 2013
Macquarie 10.25M $410.92M Dec. 31, 2013
Inves 10.24M $410.57M Dec. 31, 2013
JPMORGAN CHASE & CO 9.55M $376.50M June 30, 2012
PointState Capital 9.45M $378.57M Dec. 31, 2013
FMR 9.41M $377.26M Dec. 31, 2013
GOLDMAN SACHS 8.45M $338.58M Dec. 31, 2013
Norges Bank Investment Management 7.72M $309.46M Dec. 31, 2013
Thornburg Investment Management 6.30M $249.82M March 31, 2013
Waddell & Reed Financial 6.15M $246.53M Dec. 31, 2013
TIAA-CREF Investment Management 6.10M $252.48M Sept. 30, 2012
NWQ INVESTMENT MANAGEMENT 5.99M $240.17M Dec. 31, 2013
UBS AG 5.94M $224.40M Sept. 30, 2013
Perry 5.66M $223.14M June 30, 2012
D. E. Shaw & Co 5.55M $218.99M June 30, 2012
Owl Creek Asset Management 5.49M $247.17M March 31, 2012
Lazard Asset Management 5.36M $215.01M Dec. 31, 2013
Westfield Capital Management Company 5.17M $207.38M Dec. 31, 2013
BAILLIE GIFFORD & CO 4.89M $197.32M Dec. 31, 2011
Citi 4.89M $195.92M Dec. 31, 2013
NORDEA INVESTMENT MANAGEMENT AB 4.72M $178.22M Sept. 30, 2013
Schroder Investment Management 4.55M $182.44M Dec. 31, 2013
Frank Russell Company 4.37M $194.87M Dec. 31, 2013
MANAGED ACCOUNT ADVISORS 4.20M $158.84M Sept. 30, 2013

Who sold Teva Pharmaceutical Industries?

Fund Name Date Sold Number of Shares Sold Share Valuation
Barclays Sept. 30, 2011 4.31M $160.28M
Johnson Investment Counsel June 30, 2011 8.26M $352.53M
OppenheimerFunds June 30, 2011 5.89M $284.19M
American Century Companies June 30, 2011 4.58M $220.75M
Paulson & Co June 30, 2011 4.18M $201.63M
Jennison Associates March 31, 2011 14.48M $726.54M
ALLIANCEBERNSTEIN March 31, 2011 8.88M $445.50M
ARTIO GLOBAL Management March 31, 2011 4.97M $249.17M
Bank of America Corporation March 31, 2011 4.62M $231.94M
Marsico Capital Management Dec. 31, 2010 5.45M $284.09M
Maverick Capital Dec. 31, 2010 4.79M $249.48M
William Blair $ Company Dec. 31, 2010 4.30M $224.11M
FIL Dec. 31, 2010 4.18M $216.79M